Japan-U.S. Research Team IDs Gene Behind Kawasaki Disease (Japan)
This article was originally published in PharmAsia News
A team of Japanese and U.S. researchers says it has made the first identification of a gene associated with Kawasaki disease that can cause coronary artery aneurysms. The isolated gene is one of several factors believed associated with the disease, which has no cure, and its presence increases by 90 percent the risk of contracting the disease. The protein of the gene is believed to be lacking in people with Kawasaki disease, allowing their immune systems to overreact. (Click here for more
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.